Social anxiety disorder

World Journal of Biological Psychiatry

Volumn 4, Issue 3, 2003, Pages 103-110

  Kaminer, Debra ^a   Stein, Dan J ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

social anxiety disorder; social phobia

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

HUMAN; PHOBIA; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; REVIEW;

HUMANS; PHOBIC DISORDERS; PSYCHOTHERAPY; SEROTONIN UPTAKE INHIBITORS;

EID: 0642305519     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622970310029902     Document Type: Review

References (84)

1. Alden LE (1989) Short-term structured treatment for avoidant personality disorder. J Consult Clin Psychol 57:756-764.
2. Altamura AC, Pioli R, Vitto M, Mannu P (1999) Venlafaxine in social phobia: a study in selective serotonin reuptake inhibitor non-responders. Int Clin Psychopharmacol 14:239-245.
3. American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders 3rd edition. Washington, DC.
4. American Psychiatric Association (2002) Diagnostic and statistical manual of mental disorders 4th edition, text revision. Washington, DC.
5. van Ameringen M, Mancini C, Wilson C (1996) Buspirone augmentation of selective serotonin reuptake inhibitors (SSRIs) in social phobia. J Affect Disord 39:115-121.
6. van Ameringen MA, Lane RM, Walker JR, Bowen RC, Chokka PR, Goldner EM, Johnston DG, Lavallee YJ, Nandy S, Pecknold JC, Hadrava V, Swinson RP (2001) Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study. Am J Psychiatry 158:275-281.
7. Ballenger JC, Davidson JA, Lecrubier Y, Nutt DJ (1998) Consensus statement on social anxiety disorder from the international consensus group on depression and anxiety. J Clin Psychiatry 59:54-60.
8. Blanco C, Schneier FR, Liebowitz MR (2002) Pharmacotherapy for social phobia. In: Stein DJ, Hollander E (eds) Textbook of anxiety disorders. American Psychiatric Publishing, Washington DC, pp 309-321.
9. Boyd JH, Rae DS, Thompson JW, Burns, BJ, Bourdon K, Locke BZ, Regier DA (1990) Phobia: prevalence and risk factors. Soc Psychiatry Psychiatr Epidemiol 25:314-323.
10. Brown EB, Heimberg RG, Juster HR (1995) Social phobia sub-type and avoidant personality disorder: effect on severity of social phobia, impairment and outcome of cognitive-behavioral treatment. Behavior Therapy 26:467-486.
11. Cappe RF, Alden LE (1986) A comparison of treatment strategies for clients functionally impaired by extreme shyness and social avoidance. J Consult Clin Psychol 54:796-801.
12. Chang SC (1997) Social anxiety (phobia) and east Asian culture. Depress Anxiety 5:115-120.
13. Chavira DA, Stein MB (2002) Phenomenology of social phobia. In: Stein DJ, Hollander E (eds) Textbook of anxiety disorders. American Psychiatric Publishing, Washington DC, pp 289-300.
14. Chavira DA, Stein MB, Malcarne VL (2002) Scrutinizing the relationship between shyness and social phobia. L Anx Disorders 16:585-598.
15. Clarke DM, Wells A (1995) A cognitive model of social phobia. In: Heimberg RG, Liebowitz MR, Hope DA, Schneier FR (eds) Social phobia: diagnosis, assessment and treatment. Guilford, New York, pp 69-93.
16. Connor KM, Davidson JR, Churchill LE, Sherwood A, Foa E, Weisler RH (2000) Psychometric properties of the Social Phobia Inventory (SPIN). Br J Psychiatry 176:379-386.
17. Davidson JRT, Potts NLS, Richichi EA, Krishnan RR, Ford SM, Smith R, Wilson W (1991) The Brief Social Phobia Scale. J Clin Psychiatry 52:48-51.
18. Davidson JRT, Potts NLS, Richichi EA (1993) Treatment of social phobia with clonazepam and placebo. J Clin Psychopharmacol 13:423-428.
19. Davidson JRT, Miner CM, De Veaugh-Geiss, Tupler LA, Colket, TJ, Potts NLS (1997) The Brief Social Phobia Scale: a psychometric evaluation. Psychol Med 27:161-166.
20. Degonda M, Angst J (1993) The Zurich study, XX: social phobia and agoraphobia. Eur Arch Psychiatry Clin Neurosci 243:95-102.
21. Deltito JA, Stam M (1989) Psychopharmacological treatment of avoidant personality disorder. Compr Psychiatry 30:498-504.
22. DiNardo PA, Brown TA, Barlow DH (1994) Anxiety Disorders Interview Schedule for DSM-IV: Lifetime version (ADIS-IV-L). Graywind, Albany, NY.
23. DiNardo PA, Brown TA, Lawton JK, Barlow DH (1995) The Anxiety Disorders Interview Schedule for DSM-IV Lifetime Version: description and initial evidence for diagnostic reliability. Paper presented at the 29th annual meeting of the Association for the Advancement of Behavior Therapy, Washington DC, November 1995.
24. Fairbanks JM, Pine DS, Tancer NK, Dummit ES, Kentgen LM, Martin J, Asche BK, Klein RG (1997) Open fluoxetine treatment of mixed anxiety disorders in children and adolescents. J Child Adolesc Psychopharmacol 7:17-29.
25. Feske U, Chambless DL (1995) Cognitive-behavioral versus exposure treatment for social phobia: a meta-analysis. Behavior Therapy 26:695-720.
26. First MB, Spitzer RL, Gibbon M, Williams J (1996) Structured Clinical Interview for DSM-IV Axis I disorders - Patient Edition (SCID-I/P, Version 2). New York State Psychiatric Institute, New York.
27. Furmark T, Tillfors M, Marteinsdottir I, Fischer H, Pissiota A, Langstroem B, Fredrikson M (2002) Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy. Arch Gen Psych 59:425-433.
28. Fyer A, Mannuzza S, Chapman T (1993) A direct interview family study of social phobia. Arch Gen Psychiatry 50:286-293.
29. Gates GA, Saegert P, Wilson N, Johnson L, Shepherd A, Hearne EM (1985) Effects of beta blockade on singing performance. Ann Otol Rhinol Laryngol 94:570-574.
30. Gelernter CS, Uhde TW, Cimbolic P, Arnkoff DB, Vittone BJ, Tancer ME, Bartko JJ (1991) Cognitive-behavioral and pharmacological treatments of social phobia: a controlled study. Arch Gen Psychiatry 48:938-945.
31. Glass CR, Merluzzi TV, Biever JL, Larson KH (1982) Cognitive assessment of social anxiety: development and validation of a selfstatement questionnaire. Cognitive Therapy and Research 38:37-55.
32. Hartley LR, Ungap S, Davie I, Spencer DJ (1983) The effect of beta social anxiety disorder with or without co-morbid anxiety disorder. blocking drugs on speaker's performance and memory. Br J Psychiatry 142:512-517.
33. Herbert JD, Hope DA, Bellack AS (1991) Validity of the distinction between generalized social phobia and avoidant personality disorder. J Abnorm Psychol 101:332-339.
34. Heimberg RG, Mueller GP, Holt CS, Hope DA, Liebowitz MR (1992) Assessment of anxiety in social interaction and being observed by others: the Social Interaction Anxiety Scale and the Social Phobia Scale. Behavior Therapy 23:53-73.
35. Heimberg RG, Liebowitz MR, Hope DA, Schneier FR, Holt CS, Welkowitz LA, Juster HR, Campeas R, Bruch MA, Cloitre M, Fallon B, Klein DF (1998) Cognitive-behavioral group therapy versus phenelzine in social phobia: 12 week outcome. Arch Gen Psychiatry 55:1133-1141.
36. Heimberg RG, Horner KJ, Juster HR, Safren SA, Brown EJ, Schneier FR, Liebowitz MR (1999) Psychometric properties of the Liebowitz Anxiety Scale. Psychol Med 29:199-212.
37. Hirshfeld-Becker DR, Fredman SJ, Robin JA, Rosenbaum JF (1999) The aetiology of social anxiety disorder. In: Westenberg HGM and den Boer JA (eds) Focus on psychiatry vol. 2: social anxiety disorder. Syn-thesis, Amsterdam, pp 47-80.
38. Kagan J, Reznick JS, Snidman N (1988) Biological bases of childhood shyness. Science 240:167-171.
39. Kagan J (1994) Galen's Prophecy: Temperament in human nature. Basic Books, New York.
40. Katzelnick DJ, Kobak KA, DeLiere T, Henk HJ, Griest JH, Davidson JRT, Schneier FR, Stein MB, Helstad CP (2001) Impact of generalized social anxiety disorder in managed care. Am J Psychiatry 158:1999-2007.
41. Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ (1992) The genetic epidemiology of phobias in women: the interrelationship of agoraphobia, social phobia, situational phobia, and simple phobia. Arch Gen Psychiatry 49:273-281.
42. Leary MR (1983) A brief version of the Fear of Negative Evaluation Scale. Personality and Social Psychology Bulletin 9:371-375.
43. Lépine JP, Pélissolo A (1998) Social phobia and alcoholism: a complex relationship. J Affect Disord 50 supl 1:
44. Lépine JP, Pélissolo A (1999) Epidemiology and co-morbidity of social anxiety disorder. In: Westenberg HGM, den Boer JA (eds) Focus on psychiatry: social anxiety disorder. Syn-thesis, Amsterdam, pp 29-26.
45. Liebowitz MR (1987) Social phobia. Mod Probl Pharmacopsychiatry 22:141-173.
46. Liebowitz MR, Schneier FR, Campeas R (1992) Phenelzine versus atenolol in social phobia: a placebo controlled comparison. Arch Gen Psychiatry 49:290-300.
47. Liebowitz MR, Heimberg RG, Schneier FR, Hope DA, Davies S, Holt CS, Goetz D, Juster HR, Lin SH, Bruch MA, Marshall RD, Klein DF (1999) Cognitive-behavioral group therapy versus phenelzine in social phobia: long-term outcome. Depress Anxiety 10:89-98.
48. Liebowitz MR, Michael R, Heimberg RG, Fresco DM, Travers J, Stein MB (2000) Social phobia or social anxiety disorder: what's in a name? Arch Gen Psychiatry 57:191-192.
49. van der Linden GJH, Stein DJ, van Balkom AJLM (2000) The efficacy of the selective serotonin reuptake inhibitors for social anxiety disorder (social phobia): A meta-analysis of randomized controlled trials. Int Clin Psychopharmacol 15S 2:15-24.
50. Magee WJ, Eaton WW, Wittchen HU, McGonagle KA, Kessler RC (1996) Agoraphobia, simple phobia and social phobia in the National Co-morbidity Survey. Arch Gen Psychiatry 53:159-168.
51. Mannuzza S, Fyer AJ, Klein DF, Endicott J (1986) Schedule for affective disorders and schizophrenia-lifetime version modified for the study of anxiety disorders (SADS-LA): rationale and conceptual development. J Psychiatr Res 20:317-325.
52. Mannuzza S, Schneier FR, Chapman TF, Liebowitz MR, Klein DF, Fyer AJ (1995) Generalized social phobia: reliability and validity. Arch Gen Psychiatry 52:230-237.
53. Marks IM, Mathews AM (1979) Brief standard self-rating for phobic patients. Behavior Research and Therapy 17:263-267.
54. Matsunaga H, Kiriike N, Matsui T, Iwasaki Y, Stein DJ (2001) Taijin kyofusho: A form of social anxiety disorder that responds to serotonin reuptake inhibitors? Int J Neuropyschopharmacology 4:231-237.
55. Mattick RP, Clarke JC (1998) Development and validation of measures of social phobia scrutiny fear and social interaction anxiety. Behavior Research and Therapy 36:455-470.
56. Mineka S, Zinbarg R (1995) Conditioning and ethological models of social phobia. In: Heimberg R, Liebowitz M, Hope D et al. (eds) Social phobia: diagnosis, assessment, treatment. Guilford, New York, pp 134-162.
57. Oosterbaan DB, van Dyk R (1999) Non-drug treatment for social anxiety disorder. In: Westenberg HGM, den Boer JA (eds) Focus on psychiatry: social anxiety disorder. Syn-thesis, Amsterdam, pp 191-206.
58. Pande AC, Davidson JR, Jefferson JW, Janney CA, Katzelnick DJ, Weisler RH, Greist JH, Sutherland SM (1999) Treatment of social phobia with gabapentin: a placebo controlled study. J Clin Psychopharmacol 19:341-348.
59. Rapee RM, Heimberg RG (1997) A cognitive-behavioral model of anxiety in social phobia. Behav Res Ther 35:741-756.
60. Robins LN, Helzer JE, Croughan JL, Ratcliff JS (1981) National Institute of Mental Health Diagnostic Interview Schedule: its history, characteristics and validity. Arch Gen Psychiatry 38:381-389.
61. Schneier FR, Johnson J, Hornig CD, Liebowitz MR, Weissman MM (1992) Social phobia: co-morbidity and morbidity in an epidemiologic sample. Arch Gen Psychiatry 49:282-288.
62. Skre I, Onstad S, Torgesen S (1991) High interrater reliability for the Structured Clinical Interview for DSM-III-R axis 1 (SCID-I). Acta Psychiatr Scand 84:167-173.
63. Skre I, Onstad S, Torgesen S (1993) A twin study of DSM-III-R anxiety disorders. Acta Psychiatr Scand 88:85-92.
64. Stein DJ, Bouwer C (1997) A neuro-evolutionary approach to the anxiety disorders. Anxiety Disord 11:409-429.
65. Stein MB, Kean Y (2000) Disability and quality of life in social phobia: epidemiologic findings. Am J Psychiatry 157:1606-1613.
66. Stein MB, Chartier MJ, Hazen AL, Kozak MV, Tancer ME, Lander S, Furer P, Chubaty D, Walker JR (1998) A direct-interview family study of generalized social phobia. Am J Psychiatry 155:90-97.
67. Stein DJ, Stein MB, Goodwin W, Kumar R, Hunter B (2001a) The selective serotonin reuptake inhibitor paroxetine is effective in more generalized and in less generalized social anxiety disorder. Psychopharmacology 158:267-272.
68. Stein DJ, Kasper S, Matsunaga H, Osser DN, Stein MB, van Ameringen M, Versiani M, Westenberg H, Zhang M (2001b) Pharmacotherapy of social anxiety disorder: An algorithm for primary care - 2001. Primary Care Psychiatry 7:107-110.
69. Stein MB, Sareen J, Hami S, Chao J (2001c) Pindolol potentiation of paroxetine for generalized social phobia: a double-blind, placebo-controlled, crossover study. Am J Psychiatry 158:1725-1727.
70. Stein DJ, Cameron A, Amrein R, Mongomery SA, Moclobemide Social Phobia Clinical Study Group (2002a) Moclobemide is effective and well tolerated in the long-term pharmacotherapy of social anxiety disorder with or without co-morbid anxiety disorder. Int Clin Psychopharmacol 17:161-170.
71. Stein DJ, Westenberg HGM, Liebowitz MR (2002b) Social anxiety disorder and generalized anxiety disorder: serotonergic and dopaminergic neurocircuitry. J Clin Psychiatry 63(Supp 16):12-19.
72. Stein MB, Jang KL, Livesley WJ (2002c) Heritability of social anxiety-related concerns and personality characteristics: a twin study. J Nerv Ment Dis 190:219-224.
73. Stein DJ, Versiani M, Hair T, Kumar R (2002d) Efficacy of paroxetine for relapse prevention in social anxiety disorder: A 24-week study. Arch Gen Psychiatry 59:1111-1118.
74. Taylor S (1996) Meta-analysis of cognitive-behavioral treatments for social phobia. J Behav Ther Exp Psychiatry 27:1-9.
75. Turner SM, Beidel DC, Dancu CV, Stanley MA (1989) An empirically derived inventory to measure social fears and anxiety: the Social Phobia and Anxiety Inventory. Psychological Assessment 1:35-40.
76. Turner SM, Beidel DC, Jacob RG (1992) Social phobia: a comparison of specific and generalized subtypes and avoidant personality disorder. J Abnorm Psychol 101:326-331.
77. Tyrer PJ, Emmanuel JS (1999) Social anxiety disorder from the perspectives of ICD-10 and DSM IV: clinical picture and classification. In: Westenberg HGM, den Boer JA (eds) Focus on psychiatry: social anxiety disorder. Syn-thesis, Amsterdam, pp 11-28.
78. Versiani M, Nardi AE, Mundim FD, Alves AB, Liebowitz MR, Amrein R (1992) Pharmacotherapy of social phobia: a controlled study with moclobemide and phenelzine. Br J Psychiatry 161:353-360.
79. Vythilingum B, Stein DJ, Soifer S (2002) Is "shy bladder syndrome" a subtype of social anxiety disorder? A survey of people with paruresis. Depress Anxiety 16:84-87.
80. Watson D, Friend R (1969) Measurement of social-evaluative anxiety. J Consult Clin Psychol 33:448-457.
81. Wells JC, Tien AY, Eaton WW (1994) Risk factors for the incidence of social phobia as determined by the Diagnostic Interview Schedule in a population-based study. Acta Psychiatr Scand 90:84-90.
82. Westenberg HGM, den Boer JA (eds) (1999) Focus on psychiatry vol. 2: social anxiety disorder. Syn-thesis, Amsterdam.
83. World Health Organisation (1990) Composite International Diagnostic Interview (CIDI). World Health Organisation, Geneva.
84. World Health Organisation (1992) ICD-10: Classification of mental and behavioural disorders: chapter V of the International Classification of Diseases, 10th edition. World Health Organisation, Geneva.